These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32474844)
1. Getting to 90-90-90: Experiences from the MaxART Early Access to ART for All (EAAA) Trial in Eswatini. Walsh F; Khan S; Bärnighausen T; Hettema A; Lejeune C; Mazibuko S; Mlambo CK; Reis R; Fleming Y; Khumalo G; Zwane M; Okello V; Spiegelman D Curr HIV/AIDS Rep; 2020 Aug; 17(4):324-332. PubMed ID: 32474844 [TBL] [Abstract][Full Text] [Related]
2. Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector: the MaxART stepped-wedge randomized controlled trial. Khan S; Spiegelman D; Walsh F; Mazibuko S; Pasipamire M; Chai B; Reis R; Mlambo K; Delva W; Khumalo G; Zwane M; Fleming Y; Mafara E; Hettema A; Lejeune C; Chao A; Bärnighausen T; Okello V J Int AIDS Soc; 2020 Sep; 23(9):e25610. PubMed ID: 32949103 [TBL] [Abstract][Full Text] [Related]
3. Experiences from a community advisory Board in the Implementation of early access to ART for all in Eswatini: a qualitative study. Mlambo CK; Vernooij E; Geut R; Vrolings E; Shongwe B; Jiwan S; Fleming Y; Khumalo G BMC Med Ethics; 2019 Jul; 20(1):50. PubMed ID: 31311526 [TBL] [Abstract][Full Text] [Related]
4. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini. Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P Elife; 2020 Aug; 9():. PubMed ID: 32831169 [TBL] [Abstract][Full Text] [Related]
5. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial. Walsh FJ; Bärnighausen T; Delva W; Fleming Y; Khumalo G; Lejeune CL; Mazibuko S; Mlambo CK; Reis R; Spiegelman D; Zwane M; Okello V Trials; 2017 Aug; 18(1):383. PubMed ID: 28821264 [TBL] [Abstract][Full Text] [Related]
6. Mortality under early access to antiretroviral therapy vs. Eswatini's national standard of care: the MaxART clustered randomized stepped-wedge trial. Chao A; Spiegelman D; Khan S; Walsh F; Mazibuko S; Pasipamire M; Chai B; Reis R; Mlambo K; Delva W; Khumalo G; Zwane M; Fleming Y; Mafara E; Hettema A; Lejeune C; Bärnighausen T; Okello V HIV Med; 2020 Aug; 21(7):429-440. PubMed ID: 32458567 [TBL] [Abstract][Full Text] [Related]
7. Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction. Ogbuoji O; Geldsetzer P; Wong C; Khan S; Mafara E; Lejeune C; Walsh F; Okello V; Bärnighausen T AIDS; 2020 Feb; 34(2):267-276. PubMed ID: 31634194 [TBL] [Abstract][Full Text] [Related]
8. Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection - Eswatini, 2015-2017. MacKellar D; Williams D; Bhembe B; Dlamini M; Byrd J; Dube L; Mazibuko S; Ao T; Pathmanathan I; Auld AF; Faura P; Lukhele N; Ryan C MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(23):663-667. PubMed ID: 29902168 [TBL] [Abstract][Full Text] [Related]
9. HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort study. Kerschberger B; Schomaker M; Jobanputra K; Kabore SM; Teck R; Mabhena E; Mthethwa-Hleza S; Rusch B; Ciglenecki I; Boulle A J Int AIDS Soc; 2020 Mar; 23(3):e25458. PubMed ID: 32128964 [TBL] [Abstract][Full Text] [Related]
10. "Is it making any difference?" A qualitative study examining the treatment-taking experiences of asymptomatic people living with HIV in the context of Treat-all in Eswatini. Horter S; Wringe A; Thabede Z; Dlamini V; Kerschberger B; Pasipamire M; Lukhele N; Rusch B; Seeley J J Int AIDS Soc; 2019 Jan; 22(1):e25220. PubMed ID: 30697970 [TBL] [Abstract][Full Text] [Related]
11. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini. Ashburn K; Chouraya C; Khumalo P; Mpango L; Mthethwa N; Machekano R; Guay L; Mofenson LM PLoS One; 2021; 16(8):e0256256. PubMed ID: 34428241 [TBL] [Abstract][Full Text] [Related]
13. Identification of misdiagnosed HIV clients in an Early Access to ART for All implementation study in Swaziland. Khan S; Mafara E; Pasipamire M; Spiegelman D; Mazibuko S; Ntshalintshali N; Hettema A; Lejeune C; Walsh F; Okello V J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21756. PubMed ID: 28872273 [TBL] [Abstract][Full Text] [Related]
14. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study. Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317 [TBL] [Abstract][Full Text] [Related]
15. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865 [TBL] [Abstract][Full Text] [Related]
16. Implementation of community and facility-based HIV self-testing under routine conditions in southern Eswatini. Pasipamire L; Nesbitt RC; Dube L; Mabena E; Nzima M; Dlamini M; Rugongo N; Maphalala N; Obulutsa TA; Ciglenecki I; Kerschberger B Trop Med Int Health; 2020 Jun; 25(6):723-731. PubMed ID: 32219945 [TBL] [Abstract][Full Text] [Related]
17. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study. Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382 [TBL] [Abstract][Full Text] [Related]
18. The Cascade of Care From Routine Point-of-Care HIV Testing at Birth: Results From an 18-Months Pilot Program in Eswatini. Khumalo PN; Sacks E; Chouraya C; Tsabedze B; Masuku T; Nyoni G; Zikalala T; Nhlabatsi B; Mthethwa N; Cohn J J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1(1):S22-S27. PubMed ID: 32520911 [TBL] [Abstract][Full Text] [Related]
19. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744 [TBL] [Abstract][Full Text] [Related]
20. Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in Eswatini. Boeke CE; Khan S; Walsh F; Hettema A; Lejeune C; Spiegelman D; Okello V; Harwell J; Mazibuko S; Bärnighausen T HIV Med; 2021 Jan; 22(1):54-59. PubMed ID: 32876360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]